PDGFB

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA011972

Antibody CAB011604

Antibody CAB018341

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Malignant cells showed moderate cytoplasmic immunoreactivity. Strong positivity was observed in prostate cancers. Most malignant lymphomas were weakly stained or negative. Malignant cells generally showed weak to moderate cytoplasmic immunoreactivity. A few cases of malignant lymphomas showed strong cytoplasmic staining while a few liver cancer showed strong membranous positivity. Malignant gliomas were mainly negative. Most malignant cells showed weak to moderate cytoplasmic and additional nuclear positivity. Several cases of malignant melanomas and ovarian carcinomas displayed strong staining. Malignant lymphomas and malignant gliomas were weakly stained or negative in most cases.

Literature conformity

Partly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected